Viral vector: potential therapeutic for glioblastoma multiforme

Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies

(2019) Breanne Caffery et al.   Nanomaterials

Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth

(2018) Laura Sánchez-Hernández et al.   GENE THERAPY

Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy

(2018) Elif Ozdemir-Kaynak et al.   Frontiers in Physiology

One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?

(2018) Dieter Henrik Heiland et al.   JOURNAL OF NEURO-ONCOLOGY

In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus

(2018) Raimunda S. S. Azevedo et al.   Scientific Reports

Management of glioblastoma in elderly patients

(2017) Jacob S. Young et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model

(2017) Dwijit GuhaSarkar et al.   Molecular Oncology

Oncolytic Virotherapy for the Treatment of Malignant Glioma

(2017) Paul M. Foreman et al.   Neurotherapeutics

Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation

(2017) Sarah Jäkel et al.   Frontiers in Cellular Neuroscience

Gene Delivery in Neuro-Oncology

(2017) Karan Dixit et al.   Current Oncology Reports

Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells

(2017) Iris J. C. Dautzenberg et al.   Scientific Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery

(2016) Chuanling Zhang et al.   BIOMATERIALS

Retargeted adenoviruses for radiation-guided gene delivery

(2016) S A Kaliberov et al.   CANCER GENE THERAPY

Progress in glioma diagnosis, classification and treatment

(2016) Patrick Y. Wen et al.   Nature Reviews Neurology

Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis

(2016) Qi Cui et al.   Nature Communications

Complement activation in Glioblastoma Multiforme pathophysiology: Evidence from serum levels and presence of complement activation products in tumor tissue

(2015) T.A.M. Bouwens et al.   JOURNAL OF NEUROIMMUNOLOGY

Sui generis: gene therapy and delivery systems for the treatment of glioblastoma

(2015) J. R. Kane et al.   NEURO-ONCOLOGY

In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells

(2015) Brienne A. McKenzie et al.   NEURO-ONCOLOGY

Adenoviral vector-mediated gene therapy for gliomas: coming of age

(2014) Maria G Castro et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Intratumoral Decorin Gene Delivery by AAV Vector Inhibits Brain Glioblastomas and Prolongs Survival of Animals by Inducing Cell Differentiation

(2014) Hsin-I Ma et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

(2013) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

(2013) Jiri Polivka et al.   PHARMACOLOGY & THERAPEUTICS

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Strategies in Gene Therapy for Glioblastoma

(2013) Aneta Kwiatkowska et al.   Cancers

The Definition of Primary and Secondary Glioblastoma

(2012) H. Ohgaki et al.   CLINICAL CANCER RESEARCH

Current status of gene therapy for brain tumors

(2012) Andrea M. Murphy et al.   Translational Research

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

(2011) W. Wu et al.   NEURO-ONCOLOGY

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

(2011) D. Ostertag et al.   NEURO-ONCOLOGY

Oncolytic parvoviruses as cancer therapeutics

(2010) Jean Rommelaere et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma

(2010) Erik HP van Putten et al.   Future Oncology

Antiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate

(2010) Haiyan Guo et al.   JOURNAL OF GENE MEDICINE

Chromosomal Integration of Adenoviral Vector DNA In Vivo

(2010) S. L. Stephen et al.   JOURNAL OF VIROLOGY

A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics

(2010) M. Puntel et al.   JOURNAL OF VIROLOGY

Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics

(2010) Camilla Krakstad et al.   Molecular Cancer

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

(2010) K. Geletneky et al.   NEURO-ONCOLOGY

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics

(2010) M. Candolfi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression

(2009) Charn-Jung Chang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-β

(2009) D H Meijer et al.   CANCER GENE THERAPY

Genetic alterations and signaling pathways in the evolution of gliomas

(2009) Hiroko Ohgaki et al.   CANCER SCIENCE

High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment

(2009) Poonam Balani et al.   MOLECULAR THERAPY

Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer Therapy

(2009) Chunxiao Wu et al.   MOLECULAR THERAPY

Oncolytic viral therapy of malignant glioma

(2009) Jacqueline Nuss Parker et al.   Neurotherapeutics

Quantitative proteomic analysis of lentiviral vectors using 2-DE

(2009) Jérôme Denard et al.   PROTEOMICS

Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy

(2008) Y Gao et al.   CANCER GENE THERAPY

Gene Therapy Using Adeno-Associated Virus Vectors

(2008) S. Daya et al.   CLINICAL MICROBIOLOGY REVIEWS

Oncolytic measles virus strains in the treatment of gliomas

(2008) Cory Allen et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Gene therapy progress and prospects cancer: oncolytic viruses

(2008) T-C Liu et al.   GENE THERAPY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE